ATE220330T1 - Deltorphin zur behandlung von ischemie - Google Patents

Deltorphin zur behandlung von ischemie

Info

Publication number
ATE220330T1
ATE220330T1 AT99920203T AT99920203T ATE220330T1 AT E220330 T1 ATE220330 T1 AT E220330T1 AT 99920203 T AT99920203 T AT 99920203T AT 99920203 T AT99920203 T AT 99920203T AT E220330 T1 ATE220330 T1 AT E220330T1
Authority
AT
Austria
Prior art keywords
deltorphin
ischemia
seq
deltorphins
administered
Prior art date
Application number
AT99920203T
Other languages
English (en)
Inventor
Peter R Oeltgen
Mark S Kindy
Paul D Bishop
Original Assignee
Univ Kentucky Res Found
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kentucky Res Found, Zymogenetics Inc filed Critical Univ Kentucky Res Found
Application granted granted Critical
Publication of ATE220330T1 publication Critical patent/ATE220330T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99920203T 1998-05-01 1999-04-30 Deltorphin zur behandlung von ischemie ATE220330T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7123698A 1998-05-01 1998-05-01
PCT/US1999/009452 WO1999056766A2 (en) 1998-05-01 1999-04-30 Method for treating ischemia

Publications (1)

Publication Number Publication Date
ATE220330T1 true ATE220330T1 (de) 2002-07-15

Family

ID=22100105

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99920203T ATE220330T1 (de) 1998-05-01 1999-04-30 Deltorphin zur behandlung von ischemie

Country Status (11)

Country Link
EP (1) EP1073451B1 (de)
JP (1) JP2003522727A (de)
AT (1) ATE220330T1 (de)
AU (1) AU756200B2 (de)
BR (1) BR9909876A (de)
CA (1) CA2325387A1 (de)
DE (1) DE69902096T2 (de)
MX (1) MXPA00010616A (de)
NZ (1) NZ507523A (de)
WO (1) WO1999056766A2 (de)
ZA (1) ZA200005920B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900178B2 (en) 2000-09-12 2005-05-31 University Of Kentucky Research Foundation Protection against ischemia and reperfusion injury
US6875742B2 (en) 2000-10-10 2005-04-05 Zymogenetics, Inc. Method for treating cytokine mediated hepatic injury
US6645938B2 (en) * 2000-10-10 2003-11-11 Zymogenetics, Inc. Protection against ischemia and reperfusion injury
KR20040096554A (ko) 2002-02-06 2004-11-16 비코르 테크놀로지스 인코포레이티드 경색방지 분자
EP2286731B1 (de) 2003-10-17 2012-05-09 Tyco Healthcare Group LP Chirurgische Klammervorrichtung
US7705119B1 (en) 2007-04-09 2010-04-27 University Of Kentucky Research Foundation Compositions and methods useful for treating circulatory and hypovolemic shock

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656420A (en) * 1995-02-24 1997-08-12 University Of Kentucky Research Foundation Method for employing the delta opioid dadle to extend tissue survival time during ischemia

Also Published As

Publication number Publication date
WO1999056766A3 (en) 2003-04-17
EP1073451A2 (de) 2001-02-07
ZA200005920B (en) 2003-03-05
DE69902096T2 (de) 2003-02-27
DE69902096D1 (de) 2002-08-14
JP2003522727A (ja) 2003-07-29
AU3775899A (en) 1999-11-23
EP1073451A3 (de) 2003-06-04
MXPA00010616A (es) 2002-07-02
WO1999056766A2 (en) 1999-11-11
EP1073451B1 (de) 2002-07-10
CA2325387A1 (en) 1999-11-11
NZ507523A (en) 2002-09-27
BR9909876A (pt) 2000-12-19
AU756200B2 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
KR100190454B1 (ko) 모다피닐의 용도
CA2596597A1 (en) Method for stimulation collagen synthesis and/or kgf expression
US10323240B2 (en) Compositions and methods of using chondroitinase ABCI mutants
BR0214967A (pt) Composto, sal famaceuticamente aceitável, processo para a preparação de um composto, composição farmacêutica, uso de um composto e método de tratar um distúrbio de um paciente
DE69939705D1 (de) Behandlung der pompeschen krankheit
MX348062B (es) Mutantes que degradan proteoglicanos para tratamiento del snc.
ATE314083T1 (de) Lysin enthaltende peptide zur behandlung von herzkrankheiten
WO2003005954B1 (en) Methods and materials for the treatment of testosterone deficiency in men
EA200701017A1 (ru) Применение рибозы-цистеина для лечения гипоксии
MXPA04003773A (es) Uso de leptina para tratar lipoatrofia humana y metodo para determinar la predisposicion a dicho tratamiento.
ATE220330T1 (de) Deltorphin zur behandlung von ischemie
WO2004004664A3 (en) Methods for treating or preventing ischemic injury
RU2099078C1 (ru) Средство, обладающее антистрессовым, стресспротекторным, ноотропным, антиалкогольным и антинаркотическим действием, способы профилактики и лечения с его использованием
DE69721462D1 (de) Verfahren zur Förderung von Ovulation und Geburt bei Säugetieren
Gyarfas et al. Central inhibitory effects of carbon dioxide. IV. Convulsive phenomena
He et al. Motoneuronal death without expression of NADPH-diaphorase activity after sciatic nerve cut in 5-day-old mice
Neerunjun et al. Functional properties of muscles transplanted between normal and dystrophic mice
WO1999018123A1 (fr) Utilisation des bloqueurs des canaux potassium neuronaux et lymphocytaires dans le traitement des maladies neurologiques d'origine immunitaire
DE69904712D1 (de) Verwendung von deltorphin zur behandlung von zytokin-vermittelter leberschädigung
Yoshida et al. Effects of compound 48/80 and exogenous histamine on wound healing in mice
RU2142286C1 (ru) Способ лечения импотенции
WO2006031314A3 (en) Use of tyrphostins to stimulate neurite outgrowth
Oakes COMPARISON OF THE PENETRATION AND ELIMINATION OF CEFTRIAXONE AND MOXALACTAM IN PLASMA, URINE AND VARIOUS TISSUES OF THE RAT (ROCEPHIN, MOXAM)
RU2000101091A (ru) Способ лечения дистрофических заболеваний сетчатки и зрительного нерва

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties